Skip to main navigation Skip to search Skip to main content

Micronutrients, Frailty, and Cognitive Impairment: Design and Preliminary Results from the CogLife 2.0 Study

  • Lena Pickert
  • , Irundika H.K. Dias
  • , Alexander Thimm
  • , Johann Weber
  • , Sewa Abdullah
  • , Joris Deelen
  • , M. Cristina Polidori

    Research output: Contribution to journal › Article › peer-review

    45 Downloads (Pure)

    Abstract

    Background: Among preventive strategies against dementia, nutrition is considered a powerful one and the recently established “nutritional cognitive neuroscience of aging” is a highly active research field. Objective: The present study was designed to deeply characterize older adults across the continuum from cognitive integrity to mild cognitive impairment (MCI) and better elucidate the prognostic role of lipophilic micronutrients within their lipidomic signature. Methods: 123 participants older than 65 years across the continuum from cognitive integrity to MCI were included [49 with subjective cognitive impairment, 29 women, 72.5±5.4 years, 26 MCI, 9 women, 74.5±5.8 years and 50 without cognitive impairment, 21 women, 70.8±4.3 years]. All participants underwent neuropsychological and nutritional examination as well as comprehensive geriatric assessment with calculation of the Multidimensional Prognostic Index (MPI) as a proxy of frailty and biological age and blood withdrawal for the analyses of lipophilic micronutrients, metabolomics and oxylipidomics. One year after the evaluation, same tests are ongoing. Results: After adjustment for age, sex, daily fruit and vegetable intake and cholesterol, we found a significant positive correlation between lutein and the number of correct words in category fluency (p = 0.016). Conclusions: This result supports the importance of carotenoids as robust biomarkers of cognitive performance independent of the nutritional status and frailty of the participants, as the entire present study collective was robust (MPI 0–0.33). The complete analyses of the metabolome and the oxylipidome will hopefully shed light on the metabolic and prognostic signature of cognitive decline in the rapidly growing population at risk of frailty.
    Original languageEnglish
    Pages (from-to)S251-S263
    Number of pages13
    JournalJournal of Alzheimer's Disease
    Volume100
    Issue numbers1
    Early online date19 Jul 2024
    DOIs
    Publication statusPublished - 20 Aug 2024

    Bibliographical note

    This article is protected by copyright. This accepted manuscript version is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License [https://creativecommons.org/licenses/by-nc-nd/4.0/].

    Funding

    This work was partly funded by the Alzheimer Association (Grant Number: AARGD-22-926459) and pump priming funding from the UKRI BBSRC and MRC (Grant number: BB/W018322/1). Additionally, Alexander Thimm and Johann Weber were supported by the Koeln Fortune Program/Faculty of Medicine, University of Cologne.

    FundersFunder number
    of Medicine, University of Cologne
    UKRI BBSRC
    Alzheimer's AssociationAARGD-22-926459
    Medical Research CouncilBB/W018322/1

      UN SDGs

      This output contributes to the following UN Sustainable Development Goals (SDGs)

      1. SDG 3 - Good Health and Well-being
        SDG 3 Good Health and Well-being

      Keywords

      • Alzheimer's disease
      • frailty
      • micronutrients
      • mild cognitive impairment
      • subjective cognitive impairment

      Fingerprint

      Dive into the research topics of 'Micronutrients, Frailty, and Cognitive Impairment: Design and Preliminary Results from the CogLife 2.0 Study'. Together they form a unique fingerprint.

      Cite this